
Half of pregnant patients with a fetal malformation are misdiagnosed due to errors made by ultrasound operators. When the mass majority of fetal and maternal anomalies are screened for using ultrasound, operator error leads to risk for morbidity and mortality for both mother and baby. BioticsAI is solving this problem once and for all. BioticsAI uses AI to help obstetricians detect fetal and maternal abnormalities in ultrasound. Our AI platform tackles misdiagnosis at the source, providing autonomous, computer vision driven quality assurance and abnormality localization on every ultrasound screening conducted by our users - ensuring patients and their providers have all of the information required for a healthy pregnancy journey.

Half of pregnant patients with a fetal malformation are misdiagnosed due to errors made by ultrasound operators. When the mass majority of fetal and maternal anomalies are screened for using ultrasound, operator error leads to risk for morbidity and mortality for both mother and baby. BioticsAI is solving this problem once and for all. BioticsAI uses AI to help obstetricians detect fetal and maternal abnormalities in ultrasound. Our AI platform tackles misdiagnosis at the source, providing autonomous, computer vision driven quality assurance and abnormality localization on every ultrasound screening conducted by our users - ensuring patients and their providers have all of the information required for a healthy pregnancy journey.
Core product: AI platform for fetal ultrasound quality assessment, anomaly detection, localization, and automated reporting
Headquarters: San Francisco, CA
Founders: Robhy Bustami (CEO), Salman Khan (COO), Chaskin Saroff (CTO), Dr. Hisham Elgammal (CMO)
Notable milestone: Winner of TechCrunch Disrupt Startup Battlefield 2023
Funding (public): Pre-seed round (Sep 2023) with Techstars and Blackbird Ventures
Prenatal fetal and maternal ultrasound screening; reducing misdiagnosis from operator error.
Healthtech / Software Development
Round included participation from Techstars and Blackbird Ventures; amount not publicly disclosed in provided evidence.
“Early-stage backing from accelerator and venture programs (Techstars and Blackbird Ventures)”
| Company |
|---|